Locations:
Search IconSearch

MR Fingerprinting in Epilepsy Garners $3 Million NIH Grant

Pairing of novel imaging technique with post-processing analyses could ultimately reshape care

Researchers at Cleveland Clinic and Case Western Reserve University in Cleveland have received a $3 million, five-year R01 grant from the National Institutes of Health (NIH) to use a novel imaging method known as magnetic resonance (MR) fingerprinting to quantitatively assess brain pathology to improve epilepsy care.

Advertisement

Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy

The award supports application of the MR fingerprinting technology for use in patients with epilepsy by experts from Cleveland Clinic’s Epilepsy Center. “We will be using computer post-processing of the MR fingerprinting images, a strategy that our Epilepsy Center has already used successfully with conventional MRI,” says Cleveland Clinic staff scientist Irene Wang, PhD, who is co-principal investigator on the grant along with Dan Ma, PhD, of Case Western Reserve University.

“Our goal is to further develop machine learning algorithms to analyze the images and thereby improve diagnosis in challenging epilepsy cases,” Dr. Wang continues. “We believe this combination of innovations will allow visualization of small, subtle epileptic pathologies that we could not see before. This will aid identification of candidates for epilepsy surgery and help pinpoint where in the brain their seizures originate.”

An example is provided in the images below.

Sample images from a patient with right temporoparietal epilepsy in whom MR fingerprinting (right) was able to differentiate active from nonactive periventricular nodular heterotopia lesions when conventional T1-weighted MRI (left) was not. Whereas the conventional MRI shows uniform signal intensity of the bilateral nodules, MR fingerprinting shows distinct T1 signal increase in the nodules at the posterior part of the right lateral ventricle. These nodules were later confirmed to be the seizure onset zone by intracranial EEG monitoring. Images shown with radiological convention.

Advertisement

Dr. Wang notes that promising pilot data from this translational work was recently published in the Journal of Magnetic Resonance Imaging (2019;49:1333-1346), helping to pave the way for the work to be undertaken under the NIH grant.

Learn more about this year’s Medical Innovation Summit here.

Advertisement

Related Articles

16-NEU-2800-Kubu-101058161-650×450
What Do Patients Want from DBS for Parkinson’s Disease?

New study advances understanding of patient-defined goals

photo of a man sleeping at a desk, with a podcast icon overlay
March 15, 2024/Neurosciences/Podcast
Diagnosis and Management of Idiopathic Hypersomnia (Podcast)

Testing options and therapies are expanding for this poorly understood sleep disorder

illustration of an alzheimer brain and a packet of sildenafil pills
March 11, 2024/Neurosciences/Research
Sildenafil as an Alzheimer’s Candidate Drug: Further Support From Insurance Database and Mechanistic Studies

Real-world claims data and tissue culture studies set the stage for randomized clinical testing

brain scan showing perimesencephalic subarachnoid hemorrhage
Study Supports Less-Strict Monitoring for Nonaneurysmal Perimesencephalic SAH Without Hydrocephalus

Digital subtraction angiography remains central to assessment of ‘benign’ PMSAH

illustrated brain with the letters "AI" on a computer circuit board
As AI Tools Emerge, Be Proactive and Engaged to Shape Their Development

Cleveland Clinic neuromuscular specialist shares insights on AI in his field and beyond

histology image of a gray matter lesion in a multiple sclerosis brain
Study Suggests Protective Role for Microglia at Borders of Gray Matter Lesions in Progressive MS

Findings challenge dogma that microglia are exclusively destructive regardless of location in brain

series of digital-looking brain icons with a podcast button overlay on top
March 1, 2024/Neurosciences/Podcast
Harnessing the Power of AI in Medicine (Podcast)

Neurology is especially well positioned for opportunities to enhance clinical care and medical training

illustration of a neuron affected by multiple sclerosis
Clinical Trials in Progressive MS: An Assessment of Advances and Remaining Challenges

New review distills insights from studies over the past decade

Ad